Yes.Do you mean that the nerve synapses themselves have been damaged too, in addition to the loss of hair cells?
Yes.Do you mean that the nerve synapses themselves have been damaged too, in addition to the loss of hair cells?
I believe it was noted in phase 1 that they already experienced positive results in hearing regeneration.As positive as this might be, and I am really hoping it is successful, there could be downsides. What if when the hair cells grow back tinnitus gets 10 x louder? What if some people get tumors? What if...?
Caution must be exercised despite our need for a solution. I would wait for a completed phase 3. As I understand it, phase 1 is a very small sample of people who get a really small dose to see if it has negative effects. If phase one doesn't kill or maim anyone, they go to phase 2. Phase 2 is also only testing for negative effects using a larger test group. If phase 2 also doesn't kill or maim, then they go on to phase 3. Phase 3 is the only phase that tests to see if the drug actually works. So skipping phase 3 may not be in our best interests.
I am not as knowledgeable about this stuff as others here, but this was what I read some time ago about a different drug trial I was following.
It won't.What if when the hair cells grow back tinnitus gets 10 x louder?
¯\_(ツ)_/¯What if some people get tumors?
Bah humbug.So skipping phase 3 may not be in our best interests.
It could be spin.I believe it was noted in phase 1 that they already experienced positive results in hearing regeneration.
Also, let's just be real here, multi millions of dollars just jumped on board here recently, so I think they feel very strongly about their chances here.
I couldn't have said it better.What do you mean?
Raising lots of money and having an ostensibly successful drug in the works is NOT guaranteed to be a success.
AbbVie-Backed Startup Raises $133 Million To Fight Alzheimer's With Immunotherapy
A year later...
AbbVie Discontinued a Drug Trial. Biogen Stock Is Falling.
This could happen to Frequency Therapeutics.
Yes, but, the articles you provide talk about Alzheimer's research and drugs to cure that, as well as other brain diseases. Then the trial they discontinued was for a separate and rare brain disease they were also hoping to cure.Raising lots of money and having an ostensibly successful drug in the works is NOT guaranteed to be a success.
AbbVie-Backed Startup Raises $133 Million To Fight Alzheimer's With Immunotherapy
A year later...
AbbVie Discontinued a Drug Trial. Biogen Stock Is Falling.
This could happen to Frequency Therapeutics.
I thought it was on hearing loss?Similarly, Frequency Therapeutics is targeting mechanisms that could help aid a wide array of diseases, but the main focus is currently tinnitus.
Just for clarification, the main thing they are trying to treat is hearing loss, not tinnitus.Yes, but, the articles you provide talk about Alzheimer's research and drugs to cure that, as well as other brain diseases. Then the trial they discontinued was for a separate and rare brain disease they were also hoping to cure.
Similarly, Frequency Therapeutics is targeting mechanisms that could help aid a wide array of diseases, but the main focus is currently tinnitus.
Everything is speculation at this point.
What speaks to me is that they ran the first trial, and all the sudden a lot of additional money came out of the woodwork. I think investors had access to phase 1 results and now they really want to join.
Apparently we'll be let in on the results in a month or two
They have already said it worked.It is true that a lot of money and new partners coming in doesn't guarantee that it will work,
Yeah but did they ever see any success in humans or animals?Raising lots of money and having an ostensibly successful drug in the works is NOT guaranteed to be a success.
AbbVie-Backed Startup Raises $133 Million To Fight Alzheimer's With Immunotherapy
A year later...
AbbVie Discontinued a Drug Trial. Biogen Stock Is Falling.
This could happen to Frequency Therapeutics.
What makes you think there is a chance nerve synapses would be damaged as well?Yes.
https://www.researchgate.net/profil...s-after-noise-trauma-induced-hearing-loss.pdfWhat makes you think there is a chance nerve synapses would be damaged as well?
Are damaged nerve synapses a potential cause of hyperacusis?
Probably.Are damaged nerve synapses a potential cause of hyperacusis?
I don't think the supporting cells would get hurt from cochlear damage like sound, as they do not react to it like hair cells do. It's like skin cells being able to be damaged by those levels of sound. And yes, those cells should be able to restore any frequency so long as they are hair cells.
Perhaps that's how they came up with their name...
The reality is we don't know when there becomes too little supporting cells for this to work. But they suggest moderate hearing loss is the limit to FX-322's effective. Noise damages so many different things in the cochlea not just hair cells.Here is the publication from Frequency Therapeutics:
http://dx.doi.org/10.1016/j.celrep.2017.01.066.
I just had a quick read and think the paper says they can expand the number of positive supporting cells. So maybe even if you have some injury to your supporting cells, the drug can still work.
Sauce?Similarly, Frequency Therapeutics is targeting mechanisms that could help aid a wide array of diseases, but the main focus is currently tinnitus.
Oh, that's perfect. I have progressive hereditary hearing loss so by the time this comes out I probably won't have enough hearing for Frequency Therapeutics, either. Looks like both my tinnitus and hearing loss are here to stay . Nothing quite like having a whole bunch of new treatments for tinnitus for the first time ever, only to not be eligible for literally any of them. Staying optimistic is getting harder and harder...The reality is we don't know when there becomes too little supporting cells for this to work. But they suggest moderate hearing loss is the limit to FX-322's effective. Noise damages so many different things in the cochlea not just hair cells.
Where did they say this?But they suggest moderate hearing loss is the limit to FX-322's effective.
He requested you to source the information of your statement.Huh?
I believe @Aaron123 posted the source along time ago about "moderate hearing loss being the therapeutic limit". It is somewhere in this thread multiple times.Where did they say this?